International Flavors & Fragrances Inc. (IFF) reported full‑year 2025 sales of $10.89 billion, a 5% decline from the $11.48 billion recorded in 2024, and adjusted operating EBITDA of $2.10 billion, translating to a 19.2% margin. The company’s earnings per share came in at $0.80, missing the consensus estimate of $0.84 by $0.04, while revenue of $2.59 billion beat the $2.51 billion estimate by $0.08 billion.
In the fourth quarter, IFF generated $2.59 billion in revenue, up 1% on a comparable currency‑neutral basis, and reported an EPS of $0.80 versus the $0.84 estimate, a miss of $0.04. Segment performance was mixed: Food Ingredients delivered $802 million in sales and $82 million in adjusted operating EBITDA; Health & Biosciences posted $589 million in sales and $155 million in EBITDA; Scent generated $610 million in sales and $106 million in EBITDA; and Taste reported $588 million in sales and $94 million in EBITDA. The decline in Food Ingredients sales, down 4% YoY, was offset by growth in Health & Biosciences and Scent, which each grew 5% and 5.5% respectively on a comparable currency‑neutral basis.
The company cited several headwinds that contributed to margin compression: softer momentum in beauty and food categories, leaner retail inventories, higher raw‑material costs, and additional labor, shipping, and cleaning expenses. Gross profit fell 9.18% YoY and operating profit dropped 23.62% YoY, yet comparable currency‑neutral adjusted EBITDA increased 7% due to productivity gains and favorable net pricing. These dynamics explain the EPS miss despite the revenue beat.
Portfolio optimization continued with the launch of a sale process for the Food Ingredients segment and the divestiture of the Soy Crush, Concentrates & Lecithin business to Bunge. No sale price was disclosed, but the move aligns with IFF’s strategy to focus on high‑margin, differentiated products and improve financial flexibility.
Management guidance for 2026 projects sales of $10.5‑$10.8 billion and adjusted operating EBITDA of $2.05‑$2.15 billion. CEO Erik Fyrwald said, "IFF delivered a solid 2025 performance, meeting the full‑year financial commitments we set at the start of the year, despite a challenging operating environment." He added, "We also took steps to optimize our portfolio. Through several divestitures and the recent launch of a sale process for our Food Ingredients segment, we sharpened our strategic focus and improved our financial flexibility, allowing us to direct resources to our highest‑value businesses." "Looking ahead to 2026, we are continuing to serve our customers with leading innovation to grow profitably with them and deliver financial performance across the company. While macroeconomic uncertainty persists, we are encouraged by the strength of our pipeline and the benefits of our reinvestment actions. We enter the year confident in our ability to deliver on our priorities and create long‑term value for our shareholders."
Analysts noted the EPS miss but welcomed the revenue beat. The mixed market reaction reflected concerns over margin pressures and the company’s ongoing portfolio optimization, while some analysts upgraded the stock in light of the company’s strategic focus and confidence in future growth.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.